APPLICATIONS
IBM Selects TurboWorx Software to Build Bridge Applications for Blue Gene
TurboWorx announced its workflow and distributed computing solution will help link applications into computational workflows on IBM's Blue Gene supercomputers for unparalleled access to high performance computing. TurboWorx solutions will make it easier for customers to build and run workflows on Blue Gene. "We are pleased to have the opportunity to build our solutions on a platform as powerful as the IBM Blue Gene supercomputer." said Srini Chari, President and CEO of TurboWorx. "TurboWorx's technical strategy leverages high performance computing infrastructure to provide customers with flexible solutions to their most complex business problems. Because the value of these solutions scales in direct proportion to the power of the underlying platform, we believe that Blue Gene represents an unusual opportunity both for TurboWorx and its customers." Industries that will benefit from this new software are life sciences, financial services, defense and homeland security, and environmental and weather modeling. TurboWorx software automates and accelerates data-intensive workflows, providing increased speed in analytical data processing and resulting in significantly improved productivity. The broad applicability of Blue Gene to important supercomputing areas like life sciences can be enhanced by TurboWorx's ability to allow customers to link and wrap compute- and data-intensive applications residing on the system, resulting in an unmatched blend of workflow and distributed computing solutions. "It is very likely that the scale of systems biology problems, especially for cellular imaging, will eventually eclipse the compute capacity of commodity servers. Provisions should be made to accommodate transfer of these problems to larger compute resources such as IBM's Blue Gene machine. Together, TurboWorx and IBM provide hardware and software solutions that allow researchers to benefit from existing in-house computing resources as well as take advantage of cutting edge technology as demonstrated by Blue Gene," said Dr. Paul Matsudaira, Professor of Biology & Biological Engineering at the Massachusetts Institute of Technology. "We are excited about the prospects of working with a leading solution provider like TurboWorx to provide our clients high-performance computing solutions that help them manage, scale and allocate resources efficiently," said Dave Turek, Vice President, IBM Deep Computing. "The combination of IBM and business partner innovations is helping advance the use of supercomputing power by solving complex problems faster and reducing client's development costs." IBM eServer Blue Gene Solution provides customers with the capability to advance science and business with unprecedented speed, ultrascale performance and extreme efficiency. The system enables customers to obtain a peak performance of 5.7 teraflops, with a single rack system, and is optimized for compute density, low power consumption and scalability. With a footprint of less than one square meter, the system delivers more than 10 times the performance of other supercomputers now on the market while occupying less floor space and consuming significantly less power. TurboWorx Builder and TurboWorx Enterprise solutions run on open standards-based IBM platforms. The company's technologies enable workflow collaboration, provide integrated access to data and applications, offer significant application acceleration, and manage data, users and applications across an enterprise. IBM, working with its business partners, is making Blue Gene applicable for workloads across a variety of disciplines.